Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
7.49M
-
Shares change
-
-145K
-
Total reported value, excl. options
-
$75.4M
-
Value change
-
-$1.49M
-
Put/Call ratio
-
0.2
-
Number of buys
-
10
-
Number of sells
-
-9
-
Price
-
$10.20
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q3 2023
34 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q3 2023.
Profound Medical Corp. - Common Shares (PROF) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.49M shares
of 29.9M outstanding shares and own 25.06% of the company stock.
Largest 10 shareholders include GAGNON SECURITIES LLC (1.58M shares), FIL Ltd (1.2M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.16M shares), Gagnon Advisors, LLC (679K shares), Timelo Investment Management Inc. (673K shares), ROYCE & ASSOCIATES LP (570K shares), Raymond James Financial Services Advisors, Inc. (551K shares), Royal Bank of Canada (402K shares), BANK OF AMERICA CORP /DE/ (182K shares), and NATIONAL BANK OF CANADA /FI/ (128K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.